High risk of developing toxoplasmic encephalitis in AIDS patients seropositive to Toxoplasma gondii

Medical Microbiology and Immunology

Volumn 180, Issue 2, 1991, Pages 59-66

  Zangerle, R ^a   Allerberger, F ^b   Pohl, P ^c   Fritsch, P ^a   Dierich, M P ^b  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b Inst of Hygiene and Social Medicine   (Austria)

^c UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN G; IMMUNOGLOBULIN M;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANTIBODY TITER; ARTICLE; BRAIN INJURY; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ENCEPHALITIS; FEMALE; FLUORESCENT ANTIBODY TECHNIQUE; HIGH RISK POPULATION; HUMAN; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; SERODIAGNOSIS; TOXOPLASMA GONDII; TOXOPLASMOSIS;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ADOLESCENT; ADULT; ANIMAL; ANTIBODIES, PROTOZOAN; CASE REPORT; ENCEPHALITIS; FEMALE; HUMAN; MALE; MIDDLE AGE; TOXOPLASMA; TOXOPLASMOSIS;

EID: 0025859296     PISSN: 03008584     EISSN: 14321831     Source Type: Journal    
DOI: 10.1007/BF00193846     Document Type: Article

References (25)

1. Role of serology in the diagnosis of toxoplasmic lymphadenopathy
2. Revision of the CDC surveillance case definition for acquired immunodeficiency syndrome
3. Clinical manifestations of HIV infection
4. Evaluation of the policy of empiric treatment of suspected toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome
5. Serological study of the prevalence of toxoplasmosis in 167 patients with acquired immunodeficiency syndrome (AIDS) or chronic lymphadenopathy syndrome (LAS)
6. Untersuchungen über den Durchseuchungsgrad an Toxoplasmose in Tirol
7. Prevention of Pneumocystis carinii pneumonia relapse by pentamidine aerosol in Zidovudine-treated AIDS patients
8. Toxoplasma gondii serology in HIV-infected patients: the development of central nervous system toxoplasmosis in AIDS
9. Assessment of therapy for toxoplasma encephalitis. The TE Study Group
10. Murine model of intracerebral toxoplasmosis
11. AIDS commentary: prophylaxis of Pneumocystis carinii pneumonia: an update
12. Treatment of central nervous system toxoplasmosis with pyrimethamine/ sulfadiazine combination in 35 patients with the acquired immunodeficiency syndrome
13. Neurological manifestations of the acquired immunodeficiency syndrome (AIDS): experience at UCSF and review of the literature
14. AIDS commentary. Toxoplasmic encephalitis
15. Outbreak of central-nervous-system toxoplasmosis in Western Europe and North America
16. Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome
17. Pneumocystis carinii and Toxoplasma gondii infections in patients with AIDS
18. Central nervous toxoplasmosis in AIDS patients: efficacy of an intermittent maintenance therapy
19. Therapeutic effect of the sulfonamides on infection by an intracellular protozoon (toxoplasma)
20. A retrospective study about the use of cotrimoxazole as diagnostic support and treatment of suspected cerebral toxoplasmosis in AIDS
21. Diagnosis of toxoplasmic encephalitis in patients with acquired immunodeficiency syndrome by using a new serologic method
22. Pneumocystis carinii pneumonia: aerolised pentamidine gives effective prophylaxis
23. Central nervous system toxoplasmosis in homosexual men and parenteral drug abusers